SCHEMBL382428

SCHEMBL382428

CC(C)(C)N(C(=O)O)C(CO)c1ccccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.43
CNR2 P34972 3/20 0.43
POLQ O75417 1/20 0.38
CACNA2D1 P54289 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNB1 Q02641 1/20 0.37
CACNA1C Q13936 1/20 0.37
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380984 0.89 CNR2 (0.41) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL167206 0.88 CNR2 (0.42) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL19244866 0.86 CNR2 (0.41) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL19244870 0.84 CNR2 (0.40) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL382671 0.83 CNR1 (0.44) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL19244827 0.83 CNR2 (0.39) ACP3CNR2POLQCACNA2D1CACNA1B
SCHEMBL16715321 0.82 CNR2 (0.41) ACP3CNR2CACNA2D1CACNA1BCACNB1
SCHEMBL382042 0.81 CNR2 (0.40) ACP3CNR2RAB9ACYP1A2CYP3A4
SCHEMBL382150 0.80 CNR2 (0.39) ACP3CNR2RAB9ACYP1A2CYP3A4
SCHEMBL382379 0.80 NISCH (0.43) ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed